Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

about

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

Item

http://www.wikidata.org/entity/Q55407957

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@en

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@nl

type

Item

label

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@en

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@nl

prefLabel

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@en

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis.

@nl

P1476

Bortezomib treatment for severe refractory anti-NMDA receptor encephalitis

@en

P2093

Jin-Sun Jun

http://www.w3.org/2001/XMLSchema#string

Kon Chu

http://www.w3.org/2001/XMLSchema#string

Tae-Joon Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Won Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.

CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy

A clinical approach to diagnosis of autoimmune encephalitis.

The Laboratory Diagnosis of Autoimmune Encephalitis

Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.

Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.

P304

598-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.557

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Soon-Tae Lee

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29761122

http://www.w3.org/2001/XMLSchema#string

P932

5945964

http://www.w3.org/2001/XMLSchema#string